Literature DB >> 13928813

Ototoxicity of neomycin and other antibiotics.

W LEACH.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; DEAFNESS; EAR; KANAMYCIN; NEOMYCIN; POLYMYXIN; RISTOCETIN; STREPTOMYCIN TOXICOLOGY; VANCOMYCIN; VIOMYCIN

Mesh:

Substances:

Year:  1962        PMID: 13928813     DOI: 10.1017/s0022215100060011

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


× No keyword cloud information.
  8 in total

1.  Antibiotic Ototoxicity.

Authors: 
Journal:  Br Med J       Date:  1963-07-13

2.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Systemic absorption of Soframycin after subconjunctival injection.

Authors:  A J Bron; A B Richards; D Knight-Jones; D L Easty; D Ainslie
Journal:  Br J Ophthalmol       Date:  1970-09       Impact factor: 4.638

4.  Sensitive radioimmunoassay for vancomycin.

Authors:  K L Fong; D H Ho; L Bogerd; T Pan; N S Brown; L Gentry; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

Authors:  M S Engineer; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

7.  Cochlear toxicity of butikacin (UK-18,892), a new semisynthetic aminoglycoside antibiotic, in guinea pigs.

Authors:  A J Carter
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

Review 8.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.